- Beat earnings estimates in all of the last 4 quarters
- +99.4% price growth over the last year
- Excellent financial health (Piotroski 7/9)
Teva Pharmaceutical Industries Limited stock downgraded from Hold/Accumulate to Sell Candidate after Friday trading session
(Updated on Jul 17, 2026)
The Teva Pharmaceutical Industries Limited stock price fell by -0.590% on the last day (Friday, 17th Jul 2026) from $32.22 to $32.03. During the last trading day the stock fluctuated 2.30% from a day low at $31.96 to a day high of $32.69. The price has fallen in 8 of the last 10 days and is down by -7.53% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -376 thousand shares and in total, 3 million shares were bought and sold for approximately $97.89 million.
The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $31.21 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -2.38% during the next 3 months and, with a 90% probability hold a price between $30.47 and $34.79 at the end of this 3-month period.
TEVA Signals & Forecast
A buy signal was issued from a pivot bottom point on Wednesday, July 15, 2026, and so far it has risen 1.49%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Teva Pharmaceutical Industries Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $32.27 and $33.45. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Teva Pharmaceutical Industries Limited stock
Teva Pharmaceutical Industries Limited finds support from accumulated volume at $31.62 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.735 between high and low, or 2.30%. For the last week, the stock has had daily average volatility of 2.26%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (TEVA) For The Upcoming Trading Day Of Monday 20th
For the upcoming trading day on Monday, 20th we expect Teva Pharmaceutical Industries Limited to open at $32.23, and during the day (based on 14 day Average True Range), to move between $31.52 and $32.54, which gives a possible trading interval of +/-$1.01 (+/-3.21%) up or down from last closing price. If Teva Pharmaceutical Industries Limited takes out the full calculated possible swing range there will be an estimated 3.21% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $31.62 (1.28%) than the resistance at $34.64 (8.15%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Teva Pharmaceutical Industries Limited stock A Buy?
Teva Pharmaceutical Industries Limited holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-1.974
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on July 20, 2026 - $32.23 ( 0.609%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
TEVA Performance
Trading levels for TEVA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 32.96 | 2.90% |
| R2 | 32.68 | 2.03% |
| R1 | 32.51 | 1.49% |
| Price | 32.03 | |
| S1 | 31.94 | -0.268% |
| S2 | 31.77 | -0.81% |
| S3 | 31.49 | -1.69% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 35.38 | 10.46% |
| R2 | 35.07 | 9.49% |
| R1 | 34.64 | 8.15% |
| Price | 32.03 | |
| S1 | 31.62 | -1.28% |
| S2 | 31.48 | -1.72% |
| S3 | 31.26 | -2.40% |
TEVA Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Nov 02, 2017 | Nov 27, 2017 | Dec 12, 2017 | $0.0850 | 0.515% |
| 2 | Aug 07, 2017 | Aug 25, 2017 | Sep 14, 2017 | $0.0850 | 0.463% |
| 3 | May 11, 2017 | Jun 01, 2017 | Jun 22, 2017 | $0.340 | 1.05% |
| 4 | Feb 13, 2017 | Feb 28, 2017 | Mar 20, 2017 | $0.340 | 1.01% |
| 5 | Nov 15, 2016 | Dec 01, 2016 | Dec 20, 2016 | $0.340 | 0.94% |
FAQ
Click here for our free guide on how to buy Teva Pharmaceutical Industries Limited Stock.
Buy TEVA
A buy signal from a double bottom formation was found on Wednesday, July 15, 2026 and based on theory for this formation the price should go up by 17.46% to $37.62 within 17 trading days (Friday, August 07, 2026) since signal was issued.